Funding · Company
Arsenal Biosciences, Inc.
South San Francisco, CABiotech & Pharma
Arsenal Biosciences, Inc. of South San Francisco, CA has disclosed $579M across 3 Form D offerings filed with the SEC between Sep 9, 2022 and Sep 4, 2024.
$579M
Total disclosed
3
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$221M
Form D · Sep 9, 2022 ↗
Q3 2022
· target $231M
Filing details
HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001945638Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →